MSI Financial Services’s Myriad Genetics MYGN Stock Holding History

MSI Financial Services’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2K	Hold	131	–	–	﹤0.01%	3506
2016 Q3	$3K	Sell	131 -40	-23%	-$1.01K	﹤0.01%	3354
2016 Q2	$5K	Hold	171	–	–	﹤0.01%	3154
2016 Q1	$6K	Hold	171	–	–	﹤0.01%	3071
2015 Q4	$7K	Hold	171	–	–	﹤0.01%	2916
2015 Q3	$6K	Sell	171 -13	-7%	-$461	﹤0.01%	2322
2015 Q2	$6K	Sell	184 -328	-64%	-$11.2K	﹤0.01%	2366
2015 Q1	$18K	Buy	512 +441	+621%	+$15.8K	﹤0.01%	1855
2014 Q4	$2K	Hold	71	–	–	﹤0.01%	2410
2014 Q3	$3K	Hold	71	–	–	﹤0.01%	2286
2014 Q2	$3K	Hold	71	–	–	﹤0.01%	2246
2014 Q1	$2K	Sell	71 -110	-61%	-$3.41K	﹤0.01%	2279
2013 Q4	$4K	Buy	181 +110	+155%	+$2.78K	﹤0.01%	2054
2013 Q3	$2K	Hold	71	–	–	﹤0.01%	1961
2013 Q2	$2K	Buy	+71	New	+$2.06K	﹤0.01%	2120

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MSI Financial Services's MYGN Position: Q4 2016 in Review

MSI Financial Services held its Myriad Genetics (MYGN) position steady in Q4 2016 at 131 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #3506.

MSI Financial Services first reported a position in MYGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $18K in Q1 2015. 223 funds tracked by Wall St. Rank hold MYGN as of Q4 2016.

MSI Financial Services held 131 shares of Myriad Genetics worth $2K as of Q4 2016.
MSI Financial Services left its Myriad Genetics share count unchanged in Q4 2016.
Myriad Genetics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3506 holding.
MSI Financial Services first reported a position in Myriad Genetics in Q2 2013 and has held it in 15 quarters since.
MSI Financial Services's Myriad Genetics position peaked at $18K in Q1 2015.
223 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.